How health equity is reported and analyzed in randomized trials

This is a protocol for a Cochrane Review (Methodology). The objectives are as follows: We aim to assess methods used to assess health equity considerations, and how they are reported, in studies that have assessed cohorts of RCTs.

[1]  Kristin L. Sainani,et al.  Evaluation of Evidence of Statistical Support and Corroboration of Subgroup Claims in Randomized Clinical Trials , 2017, JAMA internal medicine.

[2]  S. Zhang,et al.  Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. O’Neill,et al.  Ageism in stroke rehabilitation studies. , 2014, Age and ageing.

[4]  Tim Evans,et al.  Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. , 2014, Journal of clinical epidemiology.

[5]  S. Sidani,et al.  Strategies to Recruit Minority persons: A Systematic Review , 2014, Journal of Immigrant and Minority Health.

[6]  Elizabeth Waters,et al.  Assessing the applicability of findings in systematic reviews of complex interventions can enhance the utility of reviews for decision making. , 2013, Journal of clinical epidemiology.

[7]  Sarah E. Rosenbaum,et al.  Policymakers’ and other stakeholders’ perceptions of key considerations for health system decisions and the presentation of evidence to inform those considerations: an international survey , 2013, Health Research Policy and Systems.

[8]  P. Tugwell,et al.  Systematic reviews need to consider applicability to disadvantaged populations: inter-rater agreement for a health equity plausibility algorithm , 2012, BMC Medical Research Methodology.

[9]  David Moher,et al.  PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity , 2012, PLoS medicine.

[10]  Parker Magin,et al.  Participant demographics reported in "Table 1" of randomised controlled trials: a case of "inverse evidence"? , 2012, International Journal for Equity in Health.

[11]  Gordon H Guyatt,et al.  Credibility of claims of subgroup effects in randomised controlled trials: systematic review , 2012, BMJ : British Medical Journal.

[12]  Sandy Oliver,et al.  Getting started with a review , 2012 .

[13]  M. Sampson,et al.  Checking reference lists to find additional studies for systematic reviews. , 2011, The Cochrane database of systematic reviews.

[14]  D. Throckmorton,et al.  Adverse effects in women: implications for drug development and regulatory policies , 2011, Expert review of clinical pharmacology.

[15]  J. Carroll,et al.  What are successful recruitment and retention strategies for underserved populations? Examining physical activity interventions in primary care and community settings , 2011, Translational behavioral medicine.

[16]  P. Tugwell,et al.  How effects on health equity are assessed in systematic reviews of interventions. , 2010, The Cochrane database of systematic reviews.

[17]  Jonathan C. Craig,et al.  Strategies for Increasing Recruitment to Randomised Controlled Trials: Systematic Review , 2010, PLoS medicine.

[18]  Josiane Bonnefoy,et al.  Assessing equity in systematic reviews: realising the recommendations of the Commission on Social Determinants of Health , 2010, BMJ : British Medical Journal.

[19]  Frank Sullivan,et al.  Strategies to improve recruitment to randomised controlled trials. , 2010, The Cochrane database of systematic reviews.

[20]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.

[21]  Carol Lefebvre,et al.  An Evidence Based Checklist for the Peer Review of Electronic Search Strategies (PRESS EBC) , 2010 .

[22]  P. Tugwell,et al.  Better evidence about wicked issues in tackling health inequities. , 2009, Journal of public health.

[23]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[24]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[25]  M. Suarez‐Almazor,et al.  Is health equity considered in systematic reviews of the Cochrane Musculoskeletal Group? , 2008, Arthritis and rheumatism.

[26]  Sonia S Anand,et al.  Sex and gender subgroup analyses of randomized trials. , 2007, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[27]  Tim Evans,et al.  Road traffic crashes: operationalizing equity in the context of health sector reform , 2003, Injury control and safety promotion.

[28]  C Bain,et al.  Threats to Applicability of Randomised Trials: Exclusions and Selective Participation , 1999, Journal of health services research & policy.

[29]  Margaret Whitehead,et al.  The Concepts and Principles of Equity and Health , 1992 .